Provided by Tiger Trade Technology Pte. Ltd.

MESOBLAST LTD

2.170
-0.050-2.25%
Volume:2.33M
Turnover:5.07M
Market Cap:2.81B
PE:-34.97
High:2.215
Open:2.200
Low:2.160
Close:2.220
52wk High:3.310
52wk Low:1.880
Shares:1.30B
Float Shares:786.49M
Volume Ratio:1.10
T/O Rate:0.30%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.062
EPS(LYR):-0.062
ROE:-9.86%
ROA:-4.11%
PB:3.54
PE(LYR):-34.97

Loading ...

Mesoblast CEO Boosts Stake in Company With AU$2.7 Million Exercise of Options

MT Newswires Live
·
Jul 21

Stock Track | Mesoblast Plummets 5.14% Intraday on Profitability and Valuation Concerns Despite CEO Share Purchase

Stock Track
·
Jul 21

Mesoblast - CEO Exercises 1.9 Mln Options at A$1.45 Each for A$2.73 Mln

THOMSON REUTERS
·
Jul 21

Mesoblast - CEO Increases Shareholding to 80.8 Mln Shares

THOMSON REUTERS
·
Jul 21

Mesoblast Ltd-mesoblast CEO Makes Investment to Increase Share Ownership

THOMSON REUTERS
·
Jul 21

3 Founder Led Stocks With Real Management Alignment Investors May Want To Watch

Simply Wall St.
·
Jul 21

Flight Centre Stock And 2 Founder Led Australian Shares Backed By Long Term Focus

Simply Wall St.
·
Jul 20

Founder Led Australian Stocks With The Clearest Growth Story Right Now

Simply Wall St.
·
Jul 17

ASX Biggest Losers

MT Newswires Live
·
Jul 17

Founder Led Stocks For Investors Watching Australian Small Caps Closely

Simply Wall St.
·
Jul 16

Flight Centre Stock And 2 Founder Run ASX Shares Worth A Closer Look

Simply Wall St.
·
Jul 15

Mesoblast Achieves Patient Treatment Target in Phase 3 Trial of Chronic Lower Back Pain

MT Newswires Live
·
Jul 14

Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain

THOMSON REUTERS
·
Jul 14

ASX Stocks Estimated To Be Trading Below Fair Value In July 2026

Simply Wall St.
·
Jul 14

3 Australian Founder Led Stocks Backed By Strong Long Term Themes

Simply Wall St.
·
Jul 13

Stock Track | Mesoblast Soars 8.93% Intraday on Upbeat Ryoncil Cell Therapy Earnings

Stock Track
·
Jul 13

Australia's Mesoblast Extends Gains on Upbeat Ryoncil Cell Therapy Earnings

Reuters
·
Jul 13

Founder Led Stocks With Real Skin In The Game

Simply Wall St.
·
Jul 12

Mesoblast (ASX:MSB) Is Up 8.7% After Strong Ryoncil Debut And FDA BLA Milestone - Has The Bull Case Changed?

Simply Wall St.
·
Jul 12

Why Retail Investors Are Tracking These 3 Australian Founder Led Stocks

Simply Wall St.
·
Jul 10